Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I added some GLGI today also.
Weeeeeeeeeeeeeeeeeeeeeeeeeee
I've been pretty busy lately and haven't had time to decide what to do with SKAS. The fact that it is a tiny holding is why it has been low priority for me.
EnerJex Resources Announces Plans to List on the New York Stock Exchange
SAN ANTONIO, TX--(Marketwired - Jun 2, 2014) - EnerJex Resources, Inc. (OTCQB: ENRJ) ("EnerJex" or the "Company") announced today that it has been cleared to submit a listing application to the NYSE MKT. The Company's ability to become listed on the NYSE MKT is subject to, among other items, maintaining a minimum market price for its common stock for a sufficient period of time as determined by the NYSE MKT.
In an effort to meet the NYSE MKT's minimum market price requirement and gain exposure to a much broader audience of institutional and retail investors, EnerJex's Board of Directors unanimously approved a one-for-fifteen reverse stock split effective after the market close on May 30, 2014. This reverse stock split was approved by shareholders at the Company's 2013 annual meeting, and will take effect with trading beginning on Monday, June 2, 2014.
A number of factors were considered by EnerJex's Board prior to making this decision, including the expectation that this reverse stock split will facilitate the listing of Enerjex's common stock for trading on the NYSE MKT. The Board believes that listing on the NYSE MKT will improve the liquidity of EnerJex's stock and increase the chances that its trading price will more accurately reflect the underlying value that the Board believes to exist. In addition, the Board believes that listing on the NYSE MKT will enhance the Company's business development opportunities and improve its access to capital at favorable terms.
In considering the impact of the reverse stock split upon the possible trading range of EnerJex's common stock, the Board took into account among other factors, the experience of three other companies that underwent a reverse stock split since the beginning of 2013 in order to qualify for listing on the NYSE MKT. The chart below shows the changes in trading volume and share price experienced by such companies during the 30 and 90 trading days immediately subsequent to such reverse stock splits becoming effective. This chart does not take every factor into consideration, and there can be no assurance of what impact, if any, this reverse stock split or the planned listing on the NYSE MKT may have on the Company's trading volume and share price.
Company 30 Day
Price Change 90 Day Price Change 30 Day Volume Change 90 Day Volume Change
Company 1 +28% +25% +353% +559%
Company 2 +12% +19% +180% +128%
Company 3 -8% +75% +45% +299%
Average +11% +40% +192% +329%
For the interim period, EnerJex's shares of common stock will continue to trade on the OTCQB market under the symbol ENRJD, with the "D" temporarily added to signify that the reverse stock split has occcured. A new CUSIP number has been assigned to the Company's common stock as a result of the reverse stock split, and EnerJex now has approximately 7.3 million common shares outstanding. Information letters will be sent to all shareholders of record by EnerJex's transfer agent, Standard Registrar and Transfer Company, and additional information about the reverse stock split can be found in the Company's Form 8-K filed today with the Securities and Exchange Commission.
Management Comments
EnerJex's CEO, Robert Watson, Jr., commented, "EnerJex has earned the ability to be on a larger stage, and I believe this transaction will prove to be rewarding for shareholders."
About EnerJex Resources, Inc.
EnerJex Resources, Inc. is an independent exploration and production company focused on the acquisition and development of oil and natural gas properties located in the mid-continent region of the United States. The Company owns oil and gas leases covering nearly 100,000 net acres in multiple prolific hydrocarbon basins located in four states including Colorado, Kansas, Nebraska, and Texas.
EnerJex's operations are focused in five distinct projects where the company produces oil and natural gas from reservoirs that are characterized by long lived reserves with low production decline rates. Within these projects, the Company has identified more than 500 low-risk drilling locations. Through its large acreage footprint in the Denver-Julesburg ("DJ") Basin, EnerJex also has significant exposure to emerging oil resource plays that are being pursued by competitors on trend with the Company's properties. EnerJex's headquarters are located in San Antonio, Texas, and additional information is available on its website at www.enerjex.com.
Forward-Looking Statements
This press release and the materials referenced herein include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements give EnerJex's current expectations or forecasts of future events. The statements in this press release regarding the completion of drilling for and commencement of operations at new wells, successful production at newly drilled wells, expected increases in overall production, the acquisition of operating assets and related agreements, any implied or perceived benefits from any current or future transaction, and any other effects resulting from any of those matters, are forward-looking statements. Such statements involve material risks and uncertainties, including but not limited to: whether newly drilled or newly acquired properties will produce at levels consistent with management's expectations; market conditions; whether we will experience equipment failures and, if they materialize, whether we will be able to fund repair work without materially impairing planned production levels or the availability of capital for further production increases; the ability of EnerJex to meet its loan covenants under the debt facility that is expected to fund the costs of the new wells and to obtain financing from other sources for continued drilling; the costs of operations; delays, and any other difficulties related to producing oil; the ability of EnerJex to integrate the newly producing assets; the ability to retain necessary skilled workers to operate the new producing wells; the price of oil; EnerJex's ability to market and sell produced minerals; the risks and effects of legal and administrative proceedings and governmental regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements are set forth in our Form 10-K filed with the SEC. EnerJex undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. EnerJex's production forecasts are dependent upon many assumptions, including estimates of production decline rates from existing wells and the outcome of future drilling activity. Although EnerJex believes the expectations and forecasts reflected in these and other forward-looking statements are reasonable, it can give no assurance they will prove to have been correct. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties.
Contact:
Contact
EnerJex Resources, Inc.
Robert Watson, Jr.
CEO
Phone: (210) 451-5545
I added more shares of CCNI today.
I've been adding more shares of CCNI today. If the CEO likes it at this price then so do I!
CCNI - I love it when a CEO makes a major purchase of shares. He purchased 100,000 shares in total between yesterday and today.
Thanks for posting that.
I haven't heard anything on PFHO.
Costar Technologies, Inc. Announces Definitive Agreement To Purchase CohuHD Camera Products Division From Cohu, Inc.
Acquisition Expected to Expand Product Offerings and Accelerate Sales Growth
COPPELL, Texas, June 4, 2014 /PRNewswire/ -- Costar Technologies, Inc. (OTC Markets Group: CSTI) announced today that it has signed a definitive agreement to acquire CohuHD, the camera products and video solutions division of Cohu, Inc. (COHU). The purchase price for CohuHD, including potential earn-out payments, is expected to be $10 million in cash, subject to certain post-closing adjustments set forth in the definitive agreement. The acquisition, which is structured as an asset purchase, is subject to customary closing conditions and is expected to be completed later this week. Costar is financing the transaction with proceeds from a new credit facility with Bank of Texas. The present CohuHD management team and other CohuHD employees are expected to join Costar following the closing of the acquisition.
CohuHD is a leading provider of video cameras and related products, specializing in IP video solutions for traffic monitoring, security, surveillance and military applications; and accessories such as cables, camera mounts, lenses and data storage devices. CohuHD is the market leader in offering high-definition video systems designed for the performance requirements associated with critical infrastructure environments, and sells to a customer base that includes corporate end-users, state and federal government agencies, original equipment manufacturers, distributors, system integrators and value-added resellers.
In making the announcement, Costar President and Chief Executive Officer James Pritchett stated, "This is a great strategic fit for Costar as we combine with one of the most well respected brands in the industry. We look forward to welcoming the team from CohuHD to Costar. The combination will yield meaningful operational benefits, together with significant synergies in many areas, including marketing, sales and product development. CohuHD's product offerings are complementary to Costar's current products and solutions, and, because Costar and CohuHD serve different channels and customers, the acquisition creates numerous cross-selling opportunities. We believe our combined sales organization will be able to expand CohuHD's product penetration in existing markets and promote CohuHD's products to new markets, accelerating the growth of our sales footprint. With the addition of CohuHD, we expect Costar to become one of the 50 largest video security companies in the world, with more than $40 million in revenue per year."
He went on to say, "The CohuHD acquisition is consistent with our strategy of providing high quality solutions to our customers. Our customers will have access to a broader product line while continuing to receive the same high level of sales, service and support that they have come to expect from Costar and CohuHD."
"We are very excited to be joining the Costar team and to carry on CohuHD's 60 year history of leadership in the video camera market," said Tom Kampfer, President and General Manager, CohuHD Division. "Our combined resources and broader product offering will generate growth opportunities for CohuHD's rugged, outdoor video cameras into new commercial channels, and access to Costar's products will enable further sales opportunities within our core transportation markets."
Costar is being advised in connection with the transaction by Alston & Bird LLP.
About Costar Technologies, Inc.
Costar Technologies, Inc. develops, designs and distributes a range of security solution products including surveillance cameras, lenses, digital video recorders and high-speed domes. Costar also develops, designs and distributes industrial vision products to observe repetitive production and assembly lines, thereby increasing efficiency by detecting faults in the production process. Headquartered in Coppell, Texas, Costar's shares currently trade on the OTC Markets Group under the ticker symbol "CSTI".
Cautionary Statement Regarding Forward Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions, that if they never materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements generally are identified by the words "expects," "anticipates," "believes," "intends," "estimates," "should," "would," "strategy," "plan" and similar expressions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These forward-looking statements include, among other things, statements regarding markets for our products and our performance in those markets, our business plans, product performance and impact, competitive offerings, impact and benefits of the transaction including potential synergies to be achieved, the transaction's impact on Costar's sales and other financial results and the timing of the transaction's closing. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. The risks, uncertainties and assumptions include developments in the marketplace for our products, competition, related products and services and general economic conditions, as well as other risks and uncertainties. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. Accordingly, we cannot give assurance that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Costar. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this press release.
CONTACT:
Scott Switzer
Chief Financial Officer
Costar Technologies, Inc.
(469) 635-6800
The SwingTrade Portfolio is up 28.3% YTD and 475.7% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102716798
The portfolio is coming close to a 5 bagger!
SWINGTRADE PORTFOLIO 05/30/2014 Update: +475.7% Since Oct. 1 2009 Inception
The SwingTrade Portfolio is up 28.3% YTD. In the last month we sold CTEI, TBTC, and some CSTI. We also purchased ALJJ.
Top Return for Closed Positions
Stocks Options
1. PFHO +3,858.8% 1. PMT Calls +145.5%
2. BIOYF/RX.V +576.7% 2. AMLN Calls +29.2%
3. ASRG +351.4%
4. PBSV +310.3%
5. ROIAK +242.9%
Symbol Shares Price Value Return
------------------------------------------------------
ALJJ 2000 $2.53 $5,060.00 20.5%
CCNI 5000 $0.45 $2,250.00 9.8%
CCNI 5000 $0.45 $2,250.00 15.4%
CSTI 200 $10.10 $2,020.00 1.0%
ETCIA 4000 $0.10 $400.00 -50.0%
GLGI 10000 $0.5099 $5,099.00 21.4%
MUEL 50 $40.00 $2,000.00 4.4%
MUEL 50 $40.00 $2,000.00 25.0%
PFHO 50 $67.99 $3,399.50 172.0%
PFHO 150 $67.99 $10,198.50 7,898.8%
SKAS 5000 $0.0637 $318.50 -29.2%
Cash $22,578.79
------------------------------------------------------
Total/Return since 10/01/09 $57,574.29 475.7%*
* Note that return includes profit/loss from transactions below.
Date Type Symbol Shares Price Amount Cash Return
---------------------------------------------------------------------------------
05/16/2014 Sell CSTI 200 $10.60 $2,120.00 $22,578.79 6.0%
05/15/2014 Buy ALJJ 2000 $2.10 -$4,200.00 $20,458.69
05/14/2014 Sell TBTC 1500 $0.93 $1,395.00 $24,658.69 16.3%
05/06/2014 Sell CTEI 4500 $0.68 $3,060.00 $23,263.69 33.3%
05/06/2014 Sell CTEI 3500 $0.6899 $2,414.65 $20,203.69 35.3%
04/30/2014 Buy CTEI 8000 $0.51 $4,080.00 $17,789.04
03/24/2014 Sell BIOYF/RX.V 500 $5.2716 $2,635.80 $21,869.04 50.9%
03/24/2014 Buy MUEL 50 $38.31 -$1,915.50 $19,233.24
03/20/2014 Buy CCNI 5000 $0.41 -$2,050.00 $21,148.74
03/10/2014 Sell JBII 100 $0.155 $15.50 $23,198.74 -96.2%
03/10/2014 Sell JBII 200 $0.155 $31.00 $23,183.24 -79.9%
03/10/2014 Sell JBII 200 $0.155 $31.00 $23,152.24 -78.8%
03/10/2014 Sell JBII 200 $0.155 $31.00 $23,121.24 -84.3%
03/10/2014 Sell JBII 100 $0.155 $15.50 $23,090.24 -97.3%
03/10/2014 Sell JBII 300 $0.155 $46.50 $23,074.74 -85.9%
03/07/2014 Buy GLGI 10000 $0.42 -$4,200.00 $23,028.24
02/19/2014 Sell FTLF 1500 $2.75 $4,125.00 $27,228.24 32.9%
02/05/2014 Sell VTSI 20000 $0.058 $1,160.00 $23,103.24 16.0%
01/28/2014 Buy BIOYF/RX.V 500 $3.4930 -$1,746.50 $21,943.24
01/18/2014 Sell CLSN_140118C0500 100 $0.00 $0.00 $23,689.74 -100.0%
01/17/2014 Buy CSTI 400 $10.00 -$4,000.00 $23,689.74
01/15/2014 Buy FTLF 1500 $2.07 -$3,105.00 $27,689.74
01/10/2014 Buy PFHO 50 $25.00 -$1,250.00 $30,794.74
01/09/2014 Sell ITSI 500 $1.24 $620.00 $32,044.74 30.5%
01/09/2014 Sell ITSI 500 $1.24 $620.00 $31,424.74 14.8%
01/09/2014 Sell ITSI 500 $1.24 $620.00 $30,804.74 11.7%
01/09/2014 Sell ITSI 500 $1.24 $620.00 $30,184.74 18.1%
01/09/2014 Sell ITSI 1000 $1.24 $1,240.00 $29,564.74 22.8%
01/07/2104 Sell IHCH 5000 $0.071 $355.00 $28,324.74 -40.8%
01/07/2014 Sell IHCH 10000 $0.071 $710.00 $27,969.74 1.4%
01/07/2014 Sell IHCH 2500 $0.071 $177.50 $27,259.74 -5.3%
01/07/2014 Sell IHCH 2500 $0.071 $177.50 $27,082.24 -12.3%
01/06/2014 Sell OPRX 750 $1.83 $1,372.50 $26,904.74 1.1%
12/24/2013 Sell CDOC 5000 $0.20 $1,000.00 $25,532.24 77.0%
12/16/2013 Sell INXSF / INX.V 5000 $0.2266 $1,133.00 $24,532.24 49.7%
12/16/2013 Sell INXSF / INX.V 4000 $0.2266 $906.40 $23,399.24 4.3%
12/16/2013 Sell PFHO 100 $33.65 $3,365.00 $22,492.84 3858.8%
12/16/2013 Sell PFHO 50 $33.65 $1,682.50 $19,127.84 280.2%
11/27/2013 Buy TBTC 1500 $0.80 -$1,200.00 $17,445.34
11/25/2013 Buy VTSI 20000 $0.05 -$1,000.00 $18,645.34
11/06/2013 Buy CCNI 5000 $0.39 -$1,950.00 $19,645.34
11/06/2013 Sell BIOYF/RX.V 500 $3.7436 $1,871.80 $21,595.34 576.7%
11/04/2013 Buy MUEL 50 $32.00 -$1,600.00 $19,723.54
10/30/2013 Sell BIOYF/RX.V 500 $3.2994 $1,649.70 $21,323.54 222.5%
10/28/2013 Sell BIOYF/RX.V 500 $2.9782 $1.489.10 $19,673.84 174.9%
10/21/2013 Sell PBSV 1000 $1.60 $1,600.00 $18,184.74 310.3%
10/21/2013 Sell PBSV 500 $1.60 $800.00 $16,584.74 86.0%
10/21/2013 Sell UPG 300 $1.55 $465.00 $15,784.74 -62.6%
10/18/2013 Sell BIOYF/RX.V 500 $2.6243 $1,312.15 $15,319.74 22.2%
09/19/2013 Buy BIOYF/RX.V 500 $2.1484 -$1,074.20 $14,007.59
09/05/2013 Sell BIOYF/RX.V 500 $2.5185 $1,259.25 $15,081.79 355.3%
09/05/2013 Sell BIOYF/RX.V 1000 $2.4372 $2,437.20 $13,822.54 125.0%
07/18/2013 Buy OPRX 750 $1.81 -$1,357.50 $11,385.34
07/18/2013 Buy PFHO 50 $8.85 -$442.50 $12,742.84
07/12/2013 Buy IHCH 5000 $0.12 -$600.00 $13,185.34
07/11/2013 Buy ITSI 500 $0.95 -$475.00 $13,785.34
07/11/2013 Sell LBMH 750 $1.68 $1,260.00 $14,260.34 72.7%
07/10/2013 Sell LBMH 750 $1.56 $1,170.00 $13,000.34 69.5%
07/03/2013 Divi LBMH 1500 $0.03 $45.00 $11,830.34
07/02/2013 Sell BNLB 5000 $0.155 $775.00 $11,785.34 49.8%
07/02/2013 Sell BNLB 5000 $0.155 $775.00 $11.010.34 49.8%
06/18/2013 Sell NROM 1000 $1.09 $1,090.00 $10,235.34 62.7%
06/18/2013 Buy BNLB 10000 $0.1035 -$1,035.00 $9,145.34
06/14/2013 Buy LBMH 750 $0.99 -$742.50 $10,180.34
05/30/2013 Sell NROM 500 $1.03 $515.00 $10,922.84 28.8%
05/16/2013 Sell MKTY 4000 $0.43 $1,720.00 $10,407.84 34.4%
05/14/2013 Buy BIOYF/RX.V 1000 $1.0833 -$1,083.30 $8,687.84
05/06/2013 Divi LBMH 750 $0.02 $15.00 $9,771.14
05/03/2013 Sell PAOS 2500 $0.25 $625.00 $9,756.14 -24.2%
05/03/2013 Buy NROM 500 $0.80 -$400.00 $9,131.14
04/23/2013 Buy ITSI 500 $1.08 -$540.00 $9,531.14
04/19/2013 Buy BIOYF/RX.V 1000 $1.0232 -$1,023.20 $10,071.14
03/23/2013 Buy MKTY 4000 $0.32 -$1,280.00 $11,094.34
03/28/2013 Sell BIOYF/RX.V 1500 $1.3067 $1,960.05 $12,374.34 136.2%
03/20/2013 Sell PFHO 50 $7.70 $385.00 $10,414.29 805.9%
03/20/2013 Sell MIGL 400 $1.46 $584.00 $10,029.29 25.9%
03/20/2013 Sell MIGL 1100 $1.46 $1,606.00 $9,445.29 5.9%
03/18/2013 Buy ITSI 500 $1.11 -$555.00 $7,839.29
03/18/2013 Sell NROM 1000 $0.95 $950.00 $8,394.29 34.5%
03/14/2013 Buy MIGL 1100 $1.41 -$1,551.00 $7,444.29
03/14/2013 Buy LBMH 750 $0.95 -$712.50 $8,995.29
03/14/2013 Buy ITSI 500 $1.05 -$525.00 $9,707.79
03/05/2013 Sell MSEH 3000 $0.154 $462.00 $10,232.79 -40.8%
03/01/2013 Sell PSIX 75 $21.40 $1,605.00 $9,770.79 25.1%
02/27/2013 Sell BIOYF/RX.V 500 $1.3488 $674.40 $8,165.79 143.8%
02/25/2013 Sell CMKG 800 $1.30 $1,040.00 $7,491.39 30.0%
02/20/2013 Sell SPIN 1500 $0.45 $675.00 $6,451.39 -40.8%
02/20/2013 Sell SPIN 500 $0.45 $225.00 $5,776.39 -64.0%
02/19/2013 Buy ETCIA 4000 $0.20 $800.00 $5,551.39
02/14/2013 Sell BNLB 5000 $0.122 $610.00 $6,351.39 35.6%
02/14/2013 Sell BNLB 5000 $0.1116 $558.00 $5,741.39 24.0%
02/06/2013 Buy CMKG 800 $1.00 -$800.00 $5,183.39
02/05/2013 Buy CDOC 5000 $0.113 -$565.00 $5,983.39
02/01/2013 Buy PBSV 500 $0.86 -$430.00 $6,548.39
01/28/2013 Sell PSIX 25 $19.95 $498.75 $6,978.39 16.7%
01/28/2013 Buy PAOS 2500 $0.33 -$825.00 $6.479.64
01/23/2013 Buy BNLB 10000 $0.09 -$900.00 $7,304.64
01/23/2013 Buy ITSI 1000 $1.01 -$1,010.00 $8,204.64
01/23/2013 Sell ITSI 500 $1.58 $790.00 $9,214.64 143.1%
01/23/2013 Sell ITSI 500 $1.19 $595.00 $8,424.64 83.1%
01/16/2013 Buy ITSI 1000 $0.65 -$650.00 $7,829.64
01/11/2013 Sell GV 500 $2.10 $1,050.00 $8,479.64 11.1%
01/07/2013 Buy CLSN_140118C0500 100 $4.50 -$450.00 $7,429.64
12/20/2012 Buy IHCH 2500 $0.075 -$187.50 $7,879.64
12/20/2012 Buy IHCH 2500 $0.081 -$202.50 $8,067.14
12/20/2012 Buy NROM 1000 $0.67 -$670.00 $8,269.64
12/03/2012 Buy GV 500 $1.89 -$945.00 $8,939.64
11/28/2012 Sell SODA 20 $37.68 $753.60 $9,884.64 2.6%
11/14/2012 Sell FFEX 800 $1.63 $1,304.00 $9,131.04 1.2%
10/18/2012 Sell NHTC 800 $1.29 $1,032.00 $7,827.04 -14.0%
10/15/2012 Sell JOEZ 800 $1.23 $984.00 $6,795.04 5.1%
10/12/2012 Sell LDRXF / LEA.V 1000 $0.431 $431.10 $5,811.04 -63.5%
10/12/2012 Sell COBR 200 $5.20 $1,040.00 $5,379.94 16.9%
10/11/2012 Buy JOEZ 800 $1.17 -$936.00 $4,339.94
09/26/2012 Sell BUKS 2000 $0.295 $590.00 $5,275.94 -7.8%
09/07/2012 Buy NROM 1000 $0.7065 -$706.50 $4,685.94
08/27/2012 Sell AAPL 1 $674.47 $674.47 $5,392.44 12.4%
08/16/2012 Divi AAPL 1 $2.65 $2.65 $4,717.97
08/15/2012 Sell VTNR 500 $1.88 $940.00 $4,715.32 -6.0%
08/13/2012 Buy IHCH 10000 $0.07 -$700.00 $3,775.32
08/10/2012 Buy MIGL 400 $1.16 -$464.00 $4,475.32
08/09/2012 Buy FFEX 800 $1.61 -$1,288.00 $4,939.32
07/31/2012 Sell TPCFF / TLA.V 1500 $0.7075 $1,061.25 $6,227.32 61.7%
07/30/2012 Buy BUKS 2000 $0.32 -$640.00 $5,166.07
07/27/2012 Sell MIGL 750 $1.80 $1,350.00 $5,806.07 168.7%
07/27/2012 Buy COBR 200 $4.45 -$890.00 $4,456.07
07/17/2012 Buy NHTC 800 $1.50 -$1,200.00 $5,346.07
07/11/2012 Buy SODA 20 $36.72 -$734.40 $6,546.07
07/06/2012 Sell ITSI 1000 $0.50 $500.00 $7,280.47 56.3%
07/02/2012 Sell AMLN_0817C23.0 100 $7.75 $775.00 $6,780.47 29.2%
06/27/2012 Buy AMLN_0817C23.0 100 $6.00 -$600.00 $6,005.47
06/22/2012 Sell GV 250 $2.20 $550.00 $6,605.47 48.6%
06/19/2012 Sell GV 250 $2.38 $595.00 $6,055.47 60.8%
06/11/2012 Sell GV 250 $2.28 $570.00 $5,460.47 67.6%
06/11/2012 Sell TPCS 1500 $0.629 $943.50 $4,890.47 -52.7%
06/04/2012 Sell MIGL 750 $0.99 $742.50 $3,946.97 47.8%
05/18/2012 Sell TPCFF / TLA.V 1500 $0.6276 $941.40 $3,204.47 43.5%
05/17/2012 Buy GV 250 $1.36 -$340.00 $2,263.07
05/11/2012 Buy GV 500 $1.48 -$740.00 $2,603.07
05/07/2012 Sell ASTC 800 $1.08 $864.00 $3,343.07 8.0%
05/02/2012 Buy MIGL 1500 $0.67 -$1,005.00 $2,479.07
04/24/2012 Buy PSIX 100 $17.10 -$1,710.00 $3,484.27
04/02/2012 Sell SGRP 500 $1.341 $670.50 $5,194.27 9.9%
03/27/2012 Sell KSW 200 $3.9199 $783.98 $4,523.77 15.6%
03/27/2012 Sell KSW 200 $3.9199 $783.98 $3,739.79 4.5%
03/26/2012 Buy MSEH 3000 $0.26 -$780.00 $2,955.81
03/22/2012 Buy AAPL 1 $602.50 -$602.50 $3,735.81
03/22/2012 Buy VTNR 500 $2.00 -$1,000.00 $4,338.31
03/20/2012 Buy TPCFF / TLA.V 3000 $0.4375 -$1,312.50 $5,338.31
03/07/2012 Buy SGRP 500 $1.22 -$610.00 $6,650.81
03/01/2012 Buy KSW 200 $3.751 -$750.20 $7,260.81
03/01/2012 Sell SNKI 50 $9.95 $497.50 $8,011.01 87.7%
02/27/2012 Sell BMRA 1000 $0.73 $730.00 $7,513.51 25.9%
02/17/2012 Buy BIOYF/RX.V 3000 $0.5532 -$1,659.60 $6,783.51
02/13/2012 Sell AXST 3000 $0.41 $1,230.00 $8,443.11 70.8%
02/08/2012 Sell PMT_0421C17.5 400 $1.35 $540.00 $7,213.11 145.5%
02/03/2012 Buy KSW 200 $3.39 -$678.00 $6,673.11
02/03/2012 Sell SNKI 50 $9.80 $490.00 $7,351.11 84.9%
02/01/2012 Buy BMRA 1000 $0.58 -$580.00 $6,861.11
01/31/2012 Sell PBSV 1000 $0.73 $730.00 $7,441.11 87.2%
01/31/2012 Buy PMT_0421C175 400 $0.55 -$220.00 $6,711.11
01/31/2012 Sell IPMN 600 $0.401 $240.60 $6,931.11 -71.8%
01/31/2012 Sell IPMN 200 $0.401 $80.20 $6,690.51 -60.7%
01/27/2012 Sell ASTC 400 $0.86 $344.00 $6,610.31 19.4%
01/13/2012 Sell OBCI 400 $2.231 $892.40 $6,266.31 11.5%
01/11/2012 Sell IBAL 200 $1.54 $308.00 $5,373.91 126.5%
01/09/2012 Sell TESS 100 $15.15 $1,515.00 $5,065.91 31.9%
01/04/2012 Sell IBAL 200 $1.39 $278.00 $3,550.91 104.4%
01/04/2012 Buy ITSI 1000 $0.32 -$320.00 $3,272.91
12/30/2011 Buy OBCI 400 $2.0001 -$800.04 $3,592.91
12/30/2011 Sell IBAL 600 $1.40 $840.00 $4,392.95 105.9%
12/27/2011 Sell GAXC 1000 $0.65 $650.00 $3,552.95 -14.5%
12/16/2011 Sell IPMN 400 $0.385 $154.00 $2,902.95 -62.3%
12/16/2011 Sell IPMN 600 $0.385 $231.00 $2,748.95 -33.6%
12/07/2011 Buy IPMN 600 $0.58 -$348.00 $2,517.95
12/07/2011 Buy PFHO 300 $0.85 -$255.00 $2,865.95
11/16/2011 Divi TESS 100 $0.15 $15.00 $3,120.95
11/01/2011 Buy AXST 3000 $0.24 -$720.00 $3,105.95
10/03/2011 Sell FONR 300 $1.63 $489.00 $3,825.95 -28.4%
09/16/2011 Buy TPCS 1500 $1.20 -$1,800.00 $3,336.95
09/16/2011 Buy IPMN 600 $1.02 -$612.00 $5,136.95
09/16/2011 Buy ASTC 400 $0.72 -$288.00 $5,748.95
08/22/2011 Sell EKCS 2000 $0.19 $380.00 $6,036.95 -38.7%
08/19/2011 Buy SPIN 500 $1.25 -$625.00 $5,656.95
08/18/2011 Divi TESS 100 $0.15 $15.00 $6,281.95
08/18/2011 Sell AUTO 1,500 $0.55 $825.00 $6,266.95 -11.3%
08/18/2011 Sell DTRX 1,500 $10.00 $1,500.00 $5,441.95 14.9%
08/12/2011 Sell KTCC 100 $3.80 $380.00 $3,941.95 -32.5%
08/12/2011 Sell KTCC 100 $3.80 $380.00 $3,561.95 -29.4%
08/04/2011 Sell LEE 700 $0.75 $525.00 $3,181.95 -29.9%
07/29/2011 Sell BUKS 1,000 $0.661 $661.00 $2,656.95 50.2%
07/08/2011 Buy SKAS 5,000 $0.09 -$450.00 $1,995.95
07/01/2011 Sell OBCI 300 $3.6499 $1,094.97 $2,445.95 27.2%
06/28/2011 Sell FKWL 400 $2.52 $1,008.00 $1,350.98 -3.1%
06/15/2011 Buy JBII 100 $4.05 -$405.00 $342.98
06/15/2011 Buy IPMN 600 $1.42 -$852.00 $747.98
06/15/2011 Buy PBSV 2000 $0.39 -$780.00 $1,599.98
05/26/2011 Sell PYNGF 4000 $0.2395 $958.00 $2,379.98 -5.1%
05/26/2011 Sell BUKS 1000 $0.76 $760.00 $1,421.98 72.7%
05/25/2011 Divi TESS 100 $0.10 $10.00 $661.98
05/25/2011 Buy OBCI 300 $2.87 -$861.00 $651.98
05/19/2011 Buy FONR 300 $2.275 -$682.50 $1,512.98
05/17/2011 Buy ASTC 800 $1.00 -$800.00 $2,195.48
05/16/2011 Sell FKWL 600 $2.30 $1,380.00 $2,995.48 9.5%
05/16/2011 Sell SMID 500 $1.85 $925.00 $1,615.48 -1.6%
05/13/2011 Sell DJRT 7000 $0.04 $280.00 $690.48 -12.7%
05/13/2011 Sell DJRT 8000 $0.04 $320.00 $410.48 -22.8%
05/11/2011 Buy LEE 700 $1.07 -$749.00 $90.48
05/11/2011 Sell DAVE 40 $9.93 $397.20 $839.48 -7.2%
05/05/2011 Buy DTRX 150 $8.70 -$1,305.00 $442.28
05/05/2011 Sell AMLJ 500 $2.48 $1,240.00 $1,747.28 96.8%
05/05/2011 Buy SPIN 1500 $0.76 -$1,140.00 $507.28
04/29/2011 Buy TESS 100 $11.789 -$1,178.90 $1,647.28
04/21/2011 Sell MLKNA 200 $0.88 $176.00 $2,826.18 -29.6%
04/21/2011 Sell MLKNA 200 $0.88 $176.00 $2,650.18 -34.8%
04/21/2011 Buy PYT.V 4000 $0.2524 -$1,009.60 $2,474.18
04/11/2011 Sell TPCS 400 $1.98 $792.00 $3,483.78 96.0%
04/11/2011 Sell TPCS 200 $1.98 $396.00 $2,691.78 115.2%
04/05/2011 Buy EKCS 2000 $0.31 -$620.00 $2,295.78
03/25/2011 Buy LDRXF / LEA.V 1000 $1.182 -$1,182.00 $2,915.78
03/24/2011 Sell LRAD 400 $2.64 $1,056.00 $4,097.78 10.0%
03/21/2011 Buy UPG 300 $4.139 -$1,241.70 $3,041.78
03/16/2011 Sell IAIC 4000 $0.19 $760.00 $4,283.48 18.8%
03/15/2011 Buy IBAL 1000 $0.68 -$680.00 $3,523.48
03/14/2011 Sell ZYXI 500 $0.83 $415.00 $4,203.48 29.7%
03/10/2011 Sell ZYXI 500 $0.75 $375.00 $3,788.48 17.2%
03/02/2011 Buy BUKS 2000 $0.44 -$880.00 $3,413.48
02/28/2011 Buy AUTO 1500 $0.62 -$930.00 $4,293.48
02/25/2011 Buy SNKI 100 $5.30 -$530.00 $5,223.48
02/23/2011 Sell ASRG 500 $3.00 $1,500.00 $5,753.48 201.0%
02/23/2011 Sell ASRG 250 $3.00 $750.00 $4,253.48 351.4%
02/22/2011 Buy DJRT 8000 $0.0518 -$414.40 $3,503.48
02/15/2011 Buy DAVE 40 $10.70 -$428.00 $3,917.88
02/15/2011 Buy FKWL 400 $2.60 -$1,040.00 $4,345.88
02/14/2011 Sell AMLJ 500 $2.07 $1,035.00 $5,385.88 64.3%
02/08/2011 Buy FKWL 600 $2.10 -$1,260.00 $4,350.88
02/04/2011 Buy INXSF / INX.V 4000 $0.2173 -$869.20 $5,610.88
02/04/2011 Sell TPCS 500 $1.86 $930.00 $6,480.08 96.9%
02/02/2011 Sell SMTX 200 $3.34 $668.00 $5,550.08 0.3%
01/18/2010 Buy SMID 500 $1.88 -$940.00 $4,882.08
01/12/2010 Buy ZYXI 1000 $0.64 -$640.00 $5,822.08
01/12/2010 Buy KTCC 100 $5.63 -$563.00 $6,462.08
01/05/2010 Buy SMTX 200 $3.33 -$666.00 $7,025.08
01/05/2010 Sell IEC 100 $8.65 $865.00 $7,691.08 76.1%
01/05/2010 Sell ASRG 750 $2.85 $2,137.50 $6,826.08 330.0%
01/05/2010 Sell IEC 100 $8.18 $818.00 $4,688.58 66.5%
12/28/2010 Buy LRAD 400 $2.40 -$960.00 $3,870.58
12/23/2010 Divi ASRG 1500 $0.16 $240.00 $4,830.58
12/15/2010 Buy DJRT 7000 $0.0458 -$320.60 $4,590.58
12/10/2010 Sell KLIC 100 $7.80 $780.00 $4,911.58 1.3%
12/07/2010 Sell AEY 250 $3.799 $949.75 $4,131.58 36.6%
12/02/2010 Buy ASRG 200 $1.05 -$210.00 $3,181.83
12/02/2010 Buy ASRG 300 $1.05 -$315.00 $3,391.83
12/02/2010 Buy MLKNA 200 $1.25 -$250.00 $3,706.83
11/30/2010 Buy MLKNA 200 $1.35 -$270.00 $3,956.83
11/17/2010 Buy INXSF / INX.V 5000 $0.1514 -$757.00 $4,226.83
11/10/2010 Sell EGAN 400 $1.29 $516.00 $4,983.83 12.2%
11/04/2010 Buy ASRG 1000 $0.70 -$700.00 $4,467.83
11/04/2010 Cover TSLA 20 $23.71 -$474.20 $5,167.83 -23.4%
11/03/2010 Sell PCCC 100 $8.43 $843.00 $5,642.03 1.6%
11/02/2010 Sell MPAA 75 $10.75 $806.25 $4,799.03 56.5%
10/29/2010 Cover VVUS -100 $7.63 -$763.00 $3,992.78 -20.2%
10/27/2010 Short VVUS 100 $6.35 $635.00 $4,755.78
10/27/2010 Buy PCCC 100 $8.295 -$829.50 $4,120.78
10/21/2010 Sell MPAA 75 $9.62 $721.50 $4,950.28 40.0%
10/13/2010 Buy TPCS 400 $1.01 -$404.00 $4,228.78
10/08/2010 Buy TPCS 700 $0.92 -$644.00 $4,632.78
10/07/2010 Buy EGAN 400 $1.15 -$460.00 $5,276.78
10/07/2010 Sell MASC 100 $5.20 $520.00 $5,736.78 17.4%
09/30/2010 Buy MASC 100 $4.43 -$443.00 $5,216.78
09/30/2010 Sell INTT 200 $3.10 $620.00 $5,659.78 -27.9%
09/29/2010 Sell INTT 200 $2.915 $583.00 $5,039.78 -32.2%
09/21/2010 Cover LAMR 20 $28.62 -$572.40 $4,456.78 -1.8%
09/17/2010 Buy JBII 200 $0.77 -$154.00 $5,029.18
09/16/2010 Sell VTRO 400 $2.20 $880.00 $5,183.18 -13.7%
09/16/2010 VTROD symbol changed to VTRO
09/10/2010 Buy JBII 200 $0.73 -$146.00 $4,303.18
09/10/2010 Buy IEC 200 $4.9118 -$982.36 $4,449.18
09/10/2010 Cover BC 40 $14.41 -$576.40 $5,431.54 -11.6%
08/25/2010 Short BC 40 $12.91 $516.40 $6,007.94
08/24/2010 Short TSLA 20 $19.22 $384.40 $5,491.54
08/23/2010 Cover ARNA -100 $6.88 -$688.00 $5,107.14 7.0%
08/20/2010 Short LAMR 20 $28.11 $562.20 $5,795.14
08/18/2010 VTRO 1/5 RS - New symbol VTROD
08/17/2010 Sell FKWL 300 $1.82 $546.00 $5,232.94 -9.9%
08/09/2010 Buy MPAA 150 $6.87 -$1,030.50 $4,686.94
08/06/2010 JBIIE symbol changed to JBII
08/05/2010 Buy AEY 250 $2.7815 -$695.38 $5.717.44
08/05/2010 Buy KLIC 100 $7.70 -$770.00 $6,412.82
08/03/2010 Buy GAXC 1000 $0.76 -$760.00 $7,182.82
08/03/2010 Sell UCIA 200 $2.06 $412.00 $7,942.82 -19.2%
08/02/2010 Short ARNA 100 $7.40 $740.00 $7,530.82
07/21/2010 Buy JBIIE 200 $0.99 -$198.00 $6,790.82
06/25/2010 Buy VTRO 2000 $0.51 -$1,020.00 $6,988.82
06/21/2010 Buy FKWL 300 $2.02 -$606.00 $8,008.82
06/16/2010 Buy KTCC 100 $5.39 -$539.00 $8,614.82
06/03/2010 Sell APNC 800 $0.85 $680.00 $9,153.82 -20.6%
05/28/2010 Divi UVIC 150 $0.09 $13.50 $8,473.82
05/27/2010 Sell AEY 200 $2.86 $572.00 $8,460.32 30.0%
05/27/2010 Sell AEY 200 $2.86 $572.00 $7,888.32 37.5%
05/27/2010 Sell IDSA 25 $16.40 $410.00 $7,316.32 1.4%
05/27/2010 JBII symbol changed to JBIIE
05/20/2010 Sell UVIC 150 $5.08 $762.00 $6,906.32 42.2%
05/18/2010 Sell IDSA 50 $18.07 $903.50 $6,144.32 79.8%
05/18/2010 Sell TELT 300 $0.50 $150.00 $5,240.82 -62.1%
05/13/2010 Buy INTT 400 $4.30 -$1,720.00 $5,090.82
05/13/2010 Sell VSTNQ 300 $1.35 $405.00 $6,810.82 -25.4%
05/12/2010 Sell VSYS 4000 $0.15 $600.00 $6,405.82 5.6%
05/06/2010 Cover DNDN -20 $49.50 -$990.00 $5,805.82 10.7%
05/06/2010 Sell BFDI 3000 $0.135 $405.00 $6,795.82 -10.0%
04/30/2010 Short DNDN 20 $55.42 $1,108.40 $6,390.82
04/30/2010 Buy VSTNQ 300 $1.81 -$543.00 $5,282.42
04/29/2010 Sell SMTX 100 $4.05 $405.00 $5,825.42 55.2%
04/27/2010 Sell KTCC 100 $5.98 $598.00 $5,420.42 7.7%
04/27/2010 Sell KTCC 100 $5.98 $598.00 $4,822.42 17.0%
04/26/2010 Buy JBII 100 $5.64 -$564.00 $4,224.42
04/23/2010 Buy KTCC 100 $5.5503 -$555.03 $4,788.42
04/21/2010 Sell SMTX 100 $3.90 $390.00 $5,343.45 49.4%
04/20/2010 Sell SMTX 100 $3.70 $370.00 $4,953.45 41.8%
04/20/2010 UVICF symbol changed to UVIC
04/19/2010 Buy IDSA 25 $16.18 -$404.50 $4,583.45
04/09/2010 Buy UCIA 200 $2.55 -$510.00 $4,987.95
03/31/2010 Buy APNC 800 $1.07 -$856.00 $5,497.95
03/25/2010 Sell STRN 100 $7.08 $708.00 $6,353.95 0.6%
03/11/2010 Sell DAAT 1000 $0.76 $760.00 $5,645.95 -15.5%
03/05/2010 Buy SMTX 300 $2.61 -$783.00 $4,885.95
03/05/2010 Buy STRN 100 $7.04 -$704.00 $5,668.95
03/02/2010 Sell ROIAK 250 $3.17 $792.50 $6,372.95 26.8%
02/26/2010 Divi UVICF 150 $0.09 $13.50 $5,580.45
02/24/2010 Buy KTCC 100 $5.11 -$511.00 $5,566.95
02/12/2010 Buy IDSA 50 $10.05 -$502.50 $6,077.95
02/12/2010 Buy AEY 200 $2.20 -$440.00 $6,580.45
02/11/2010 Sell MKRS 2500 $0.28 $700.00 $7,020.45 -6.7%
02/10/2010 Buy BFDI 3000 $0.15 -$450.00 $6,320.45
02/10/2010 Sell LBY 100 $9.37 $937.00 $6,770.45 63.0%
02/09/2010 Sell CMTX 999 $0.29 $289.71 $5,833.45 31.8%
02/09/2010 Sell LBY 100 $10.00 $1,000.00 $5,543.74 73.9%
02/08/2010 Sell ROIAK 250 $3.36 $840.00 $4,543.74 242.9%
02/08/2010 Sell CMTX 2001 $0.20 $400.20 $3,703.74 -9.1%
02/05/2010 Buy TELT 300 $1.32 -$396.00 $3,303.54
01/28/2010 Sell GAXC 700 $1.01 $707.00 $3,699.54 26.3%
01/21/2010 Sell BFDI 3000 $0.235 $705.00 $2,992.54 67.9%
01/14/2010 Sell TBUS 400 $1.72 $688.00 $2,287.54 -28.6%
01/08/2010 Sell GAXC 400 $1.04 $416.00 $1,599.54 30.0%
01/04/2010 LYBI uplisted to AMEX. New symbol LBY.
12/17/2009 Buy CMTX 3000 $0.22 -$660.00 $1,183.54
12/16/2009 Buy AEY 200 $2.08 -$416.00 $1,843.54
12/16/2009 Buy BFDI 3000 $0.14 -$420.00 $2,259.54
12/15/2009 Sell EGMI 450 $1.22 $549.00 $2,679.54 -16.4%
12/15/2009 Sell EGMI 450 $1.25 $562.50 $2,130.54 -14.4%
12/09/2009 Buy ROIAK 250 $2.50 -$625.00 $1,568.04
12/01/2009 Buy MKRS 2500 $0.30 -$750.00 $2,193.04
11/30/2009 Sell BFDI 4000 $0.18 $720.00 $2,943.04 50.0%
11/30/2009 Buy IAIC 4000 $0.16 -$640.00 $2,223.04
11/25/2009 Buy VSYS 4000 $0.142 -$568.00 $2,863.04
11/23/2009 Buy UVICF 150 $3.70 -$555.00 $3,431.04
11/19/2009 Buy JBII 300 $1.10 -$330.00 $3,986.04
11/13/2009 Sell ASRG 350 $3.35 $1,172.50 $4,316.04 147.6%
11/13/2009 Sell ASRG 350 $3.30 $1,155.00 $3,143.54 143.9%
11/12/2009 Buy BFDI 4000 $0.12 -$480.00 $1,988.54
11/11/2009 Sell OPTV 400 $1.55 $620.00 $2,468.54 1.3%
11/10/2009 Buy LYBI 200 $5.75 -$1,150.00 $1,848.54
11/05/2009 Sell UVE 100 $6.07 $607.00 $2,998.54 12.0%
11/03/2009 Buy OPTV 400 $1.53 -$612.00 $2,391.54
11/03/2009 Buy UVE 100 $5.42 -$542.00 $3,003.54
10/30/2009 Buy AMLJ 1000 $1.26 -$1,260.00 $3,545.54
10/22/2009 Sell RODM 150 $5.10 $765.00 $4,805.54 -15.3%
10/15/2009 Sell ROIAK 250 $1.75 $437.50 $4,040.54 78.6%
10/01/2009 Buy ASRG 700 $1.3528 -$946.96 $3,603.04
10/01/2009 Buy TBUS 400 $2.41 -$964.00 $4,550.00
10/01/2009 Buy ROIAK 500 $0.98 -$490.00 $5,514.00
10/01/2009 Buy RODM 150 $6.02 -$903.00 $6,004.00
10/01/2009 Buy GAXC 1100 $0.80 -$880.00 $6,907.00
10/01/2009 Buy EGMI 900 $1.46 -$1,314.00 $7,787.00
10/01/2009 Buy DAAT 1000 $0.899 -$899.00 $9,101.00
10/01/2009 Deposit Cash $10,000.00 $10,000.00
I don't know where the CCNI shares are coming from but I was happy to pick up more shares today at $0.44.
My understanding is that the benefits of accounts receivable recoveries were small on an annual basis although there was variability from quarter to quarter.
CVSL Files Registration Statement And Applies For Listing On NYSE MKT
DALLAS, May 22, 2014 /PRNewswire/ -- CVSL Inc. [OTCQX U.S.: CVSL] announced today that it has filed a registration statement on Form S-1 with the U. S. Securities and Exchange Commission related to the proposed public offering of its common stock and in connection therewith has applied to have its common stock listed on the NYSE MKT. The number of shares to be offered and the price range for the offering have not been determined.
Cantor Fitzgerald & Co. will serve as lead book runner for the proposed offering.
This offering will be made only by means of a prospectus. A copy of the preliminary prospectus, when available, may be obtained from Cantor Fitzgerald & Co., 499 Park Avenue, 5th Floor, New York, New York 10022 Attention: Capital Markets or by emailing Prospectus@Cantor.com.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About CVSL
CVSL is a growing group of micro-enterprise companies that connect social media networks into an ever-expanding virtual "community" of social commerce. CVSL companies currently include The Longaberger Company, a 40-year old maker of hand-crafted baskets and other home decor items; Your Inspiration At Home, an award-winning maker of hand-crafted spices and other gourmet food items from around the world; Tomboy Tools, a direct seller of tools designed for women as well as home security systems; Agel Enterprises, a global seller of nutritional products in gel form as well as a skin care line sold under the Ageless brand, operating in 40 countries; Paperly, which offers a line of custom stationery and other personalized products; My Secret Kitchen, a U.K.-based seller of gourmet food products; and Uppercase Living, which offers an extensive line of customizable vinyl expressions for display on walls in the home. In addition, CVSL and Golden Girls, a purchaser of gold and tradable jewelry, have signed a definitive purchase agreement, which is subject to customary closing conditions.
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this press release are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," or "will" or the negative of these terms or other comparable terminology. Such statements include statements regarding our listing on the NYSE MKT. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only expectations and involve known and unknown risks, uncertainties, and other factors; such as, our ability to continue our growth, and our ability to successfully consummate the offering and obtain a listing of our common stock on the NYSE MKT and other risks outlined under "Risk Factors" in our Annual Report on Form 10-K for our fiscal year ended December 31, 2013, our Quarterly Reports on Form 10-Q, including the Quarterly Report filed with the Securities and Exchange Commission for the quarter ended March 31, 2014, and those risks discussed in other documents we file with the Securities and Exchange Commission, which may cause our actual results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements to differ materially from expectations. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations.
CVSL Media Contact: Russell Mack (rmack@cvsl.us.com)
CVSL Investor Relations Contact: Scott Pumper (scottp@cvsl.us.com)
PFHO printed a fresh high at $69!
BioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal Suppositories
TORONTO, ONTARIO--(Marketwired - May 21, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of new RepaGyn® Hormone-Free Vaginal Suppositories.
RepaGyn® (sodium hyaluronate) is an innovative vaginal suppository recommended for the healing of the vaginal mucosa and the treatment of vaginal dryness caused by menopause, stress and chemotherapy. It is also recommended in situations where tissue repair is required after invasive vaginal surgeries and biopsy procedures. RepaGyn® vaginal suppositories can be used with or without local hormone therapy.
RepaGyn® is formulated with sodium hyaluronate, a naturally occurring compound, and offers a hormone-free treatment alternative proven to deliver symptom relief, restoration of pH balance, and tissue repair in one ovule. RepaGyn® has established clinical evidence of both efficacy and symptom relief and has been recommended by doctors and successfully used by women in several European countries including Italy, France, Belgium, Switzerland, Denmark and Poland for over 10 years under the brand names Cicatridine®, Cicatridina®, Cikatridina®, and Repadina®.
"The launch of RepaGyn® is an important milestone in the development of the BioSyent Pharma business," commented René Goehrum, CEO of BioSyent. "The product itself is consistent with our strategy of sourcing unique products that address unmet medical needs for the Canadian healthcare market, and represents a further broadening of our portfolio. The patient population that can benefit from RepaGyn® is significant."
RepaGyn® is approved by Health Canada and was in-licensed by BioSyent Pharma for exclusive marketing and distribution in Canada from FARMA-DERMA s.r.l., Italy in October of 2013. Shipments to wholesalers and pharmacies will commence in June 2014.
To learn more about RepaGyn®, please visit the website www.RepaGyn.ca.
For a direct market quote (15 minutes delay) for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.
About BioSyent Inc.
Listed on the Toronto Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth oriented specialty pharmaceutical company which searches the globe to in-license or acquire innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients and supporting the healthcare professionals that treat them.
Once a product of interest has been found, BioSyent then acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Once approved, BioSyent markets the product throughout Canada.
At the date of this press release the Company had 13,776,195 shares issued and outstanding.
This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.
The TSX Venture Exchange assumes no responsibility for the accuracy of this release and neither approves nor disapproves of the same.
Contact:
BioSyent Inc.
Mr. Rene C. Goehrum
President and CEO
(905) 206-0013
investors@biosyent.com
www.biosyent.com
ALJJ is printing fresh highs as I type!
There is a Seeking Alpha article out on ALJJ.
http://seekingalpha.com/article/2221143-alj-regional-holdings-makes-a-near-perfect-acquisition-and-rockets-higher-on-results
Sell 200 shares of CSTI at $10.60 for the SwingTrade Portfolio.
In light of the information in the PR, they have some headwinds going forward. So we are not as excited about the prospects going forward. However, the stock doesn't seem overvalued here given the book value, trailing earnings, and their prospects. So, we are selling half.
CSTI reported Q1 EPS of $0.74!
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=120950
A 325,000 share block of ALJJ crossed after the bell at $2.2534.
You tell me. :)
There is a new HOD on ALJJ at $2.28.
Not much ALJJ traded in the $1.90s. My average price in is around $2.10-2.15.
ALJ Regional Holdings Announces Second Quarter Earnings
NEW YORK, May 15, 2014 /PRNewswire/ -- ALJ Regional Holdings, Inc. (OTC Markets: ALJJ) announced results for its second quarter ended March 31, 2014.
For the three months ended March 31, 2014, ALJJ posted net income of $3.5 million and earnings per share of $0.11. For the six months ended March 31, 2014, ALJJ posted net income of $4.9 million and earnings per share of $0.16.
ALJJ acquired Faneuil, Inc. ("Faneuil") in October 2013 and Floors-N-More, LLC, dba Carpets N' More ("Carpets") in April 2014. In February 2013, ALJJ sold its subsidiary, KES Acquisition Company ("KES"). Therefore, KES' prior year operations are disclosed as a discontinued operation in our financial statements and year over year comparisons for on-going operations are not possible.
Faneuil is a leading provider of outsourcing and co-sourced services to both commercial and government entities in the healthcare, utility, toll and transportation industries. Carpets is the largest floor covering retailer in Las Vegas and provider of multiple finishing products for commercial, retail and home builder markets including all types of flooring, countertops, cabinets, window coverings and garage/closet organizers, with 5 retail locations.
Our financial statements reflect the full operations of Faneuil from October 18, 2013 through March 31, 2014, and the discontinued operations of KES from October 1, 2012 through February 5, 2013. They do not reflect any operations of Carpets as the acquisition occurred after the end of the quarter.
ALJ Regional Holdings, Inc.
(in thousands except per share)
2014
2013
3 months Ended March 31
Net Sales
$
36,408
$
0
Net Income
3,479
67,816
Net Income Per Share (Dilutive)
0.11
1.52
6 months Ended March 31
Net Sales
$
62,242
$
0
Net Income
4,950
66,306
Net Income Per Share (Dilutive)
0.16
1.49
According to Jess Ravich, ALJJ's Executive Chairman, "We were very pleased with Faneuil's results this quarter. We are running ahead of our expectations this year, due in part to growth in our healthcare vertical." Mr. Ravich also stated, "This is a very exciting time for ALJ. We have acquired two well-run companies in Faneuil and Carpets and are looking forward toward the next quarter when both are fully integrated into ALJ."
About ALJ Regional Holdings
ALJJ is the parent company of Faneuil, Inc., a leading provider of outsourcing and co-sourced services to both commercial and government entities in the healthcare, utility, toll and transportation industries and Floors-N-More, LLC, dba Carpets N' More, the largest floor covering retailer in Las Vegas and provider of multiple finishing products for commercial, retail and home builder markets including all types of flooring, countertops, cabinets, window coverings and garage/closet organizers, with 5 retail locations.
This press release contains forward-looking statements. Such statements include information regarding ALJJ's expectations, goals or intentions regarding the future, including but not limited to statements including the words "will" and "expect" and similar expressions. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially are discussed in ALJJ's Annual Report for the fiscal year ended September 30, 2013 and in its other periodic reports issued through the OTC Markets News Service and available at www.otcmarkets.com. All forward-looking statements in this release are made as of the date hereof and ALJJ assumes no obligation to update any forward-looking statement.
Buy 2,000 shares of ALJJ for $2.10 for the SwingTrade Portfolio.
Sell 1500 shares of TBTC for $0.93 for the SwingTrade Portfolio.
I'm looking for a good quarter for CSTI but I haven't boiled that down to an estimate.
We sold CTEI in the portfolio. There are some things that are funny with the company and at this time don't trust them.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=101599151
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=101599607
MUEL thoughts
1. I think revenue will increase in Q2. Q1 is seasonally weaker and backlog grew sequentially in Q1 from Q4.
2. I think margins will rebound.
3. Q1 has a history of being a funky quarter for them and this year was no exception.
4. MUEL has some options available to them from a capital market perspective now that they have turned around the business. One of those is to become an SEC filer. I expect them to make some changes in this category but exactly what that will be remains to be seen. I understand that they have started to examine their approach going forward from a capital market perspective.
CCNI prints $0.49!
You might enjoy these two articles I wrote a while back on my investment philosophy. Note what BioSyent (RX.V / BIOYF) has done since the time that I wrote it. PFHO has done better but both have been very good stocks for me. I expect both companies to have long term earnings growth from here.
My Secret Recipe: The Index Card - http://microcapclub.com/2012/10/my-secret-recipe-the-index-card/
My Secret Recipe: Shopping and a Taste Test - http://microcapclub.com/2012/10/my-secret-recipe-shopping-and-a-taste-test/
exhaust?
CCNI prints $0.47 which is up $0.025 for the day. Volume is very high at 169,263 which is almost 3x the average daily volume and it is only 45 minutes into the trading day.
I became convinced of how good CCNI was after the contest started and I can't change it. The reason for the revenue decline is that the new CEO had been focusing on shedding unprofitable business. That phase is mostly done and revenue should start trending up in one of the next few quarters. The new CEO that started a year ago has really done a stellar job of cleaning up the company and moving things forward.